<DOC>
	<DOCNO>NCT01725360</DOCNO>
	<brief_summary>Control airway inflammation cornerstone asthma management . The aim present pilot study ass whether , magnitude , leukotriene receptor antagonist ( LTRA ) add basic treatment inhaled corticosteroid ( ICS ) + long-acting betamimetics ( LABA ) might improve airway hyperresponsiveness inflammation well-controlled patient asthma .</brief_summary>
	<brief_title>Change Airway Hyperresponsiveness Mannitol Methacholine Patients With Asthma</brief_title>
	<detailed_description>All patient recruit outpatient clinic Allergology Clinical Immunology University Hospital Bern , Switzerland . Patients older 18 year younger 65 year age clinically well-controlled asthma fix combination budesonide / formoterol ( equivalent ) include sign informed consent form . Clinically well-controlled asthma define absence symptom exacerbation 8 week prior inclusion . In addition , document airway hyperresponsiveness mannitol methacholine well current non-smoker status require inclusion . Smokers , woman plan pregnancy pregnant , patient significant illness interfere feasibility result provocation test , acute asthma severe cardiovascular disease , include . At baseline , patient undergo mannitol provocation test fraction exhale nitric oxide ( FeNO ) measure . If positive , least two day later , methacholine provocation test repeat measurement FeNO perform . For standardization patient prescribe standardized ICS + LABA therapy fix combination budesonide / formoterol ( 200 / 6 µg bid ) . After two-week run-in period therapy , 10mg montelukast add 4 week treatment duration ( interim visit ) . All patient include attend final visit provocation test repeat . FEV1 assess use MasterScreen Pneumo spirometer ( Jaeger GmbH , Würzburg , Germany ) filter accord ATS recommendation . The best three value FEV1 repeatable within 100ml recorded percentage predict value calculate . Mannitol challenge test carry use protocol describe Anderson et al . Mannitol administer dry powder capsule form , inhale RS01 device ( Pharmaxis Ltd. French 's Forrest , NSW , Australia [ Trimedal AG , Brüttisellen , Switzerland ] ) . An empty capsule use control baseline . The test start 5mg increase double dos 160mg . In case response 160mg dose , dose repeat maximum cumulative dose 635mg . FEV1 measure 60 second delivery dose . The challenge stop FEV1 fell 15 % , maximum dose administer . The dose cause 15 % fall FEV1 ( PD15 FEV1 ) read interpolation plot dose-response curve . Methacholine test do accord protocol SAPALDIA Study identical protocol European Community Respiratory Health Survey ( ECRHS ) `` method 2 short-protocol '' . The provocation test start inhalation saline diluent , maximum post-diluent FEV1 record two minute later control value . All solution methacholine prepared Pharmacy University Hospital Bern . Methacholine deliver use Mefar MB3 dosimeter ( Mefar , Bovezzo , Italy ) set deliver aerosol period one second . FEV1 record 2 minute later absence 20 % fall FEV1 baseline next dose give . Methacholine b e inhale quadruple dos fall FEV1 great 20 % control value observe maximum cumulative dose 2.0 mg reach . The dose cause 20 % fall FEV1 ( PD20 FEV1 ) read interpolation plot dose-response curve . Exhaled nitric oxide measure equipment throughout study accord ATS guideline use NIOX® Nitric Oxide Analyzer compute biofeedback software Aerocrine AB , Solna , Sweden . Asthma related quality life assess apply self-administered Juniper questionnaire baseline , interim final visit . This validated questionnaire encompass 32 item cluster four domain : asthma symptom , limitation daily physical activity , emotional function , exposure environmental stimulus . Each item rat patient numerical scale range 1 ( extreme limitation ) 7 ( limitation ) . Blood sample draw baseline final visit challenge test , determination blood eosinophil eosinophil cationic protein serum level ( ECP , Pharmacia diagnostics , Uppsala , Sweden , Fisher Scientific ) . Predefined parameter interest change PD15 FEV1 mannitol-test , PD20 FEV1 methacholine-test , RDR mannitol methacholine , Asthma relate quality life , FeNO , blood eosinophil eosinophil cationic protein concentration baseline final visit . Descriptive statistical analysis method use . As parameter normally distribute , mean , standard deviation correspond 95 % confidence interval calculate StatsDirect software version 2.7.7 , Altrincham , Cheshire , UK . For PD15-FEV1 , PD20-FEV1 , RDR , FeNO base 10 antilog calculate previously suggest . The study approve Ethics Committee University Hospital Bern ( KEK-BE 240/06 ) , Switzerland .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Respiratory Hypersensitivity</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Methacholine Chloride</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>clinically wellcontrolled asthma Smokers woman plan pregnancy pregnant patient significant illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>asthma</keyword>
	<keyword>airway hyperresponsiveness</keyword>
</DOC>